AngioQFA
OtherFFR measured by pressure wire, AngioQFA computed by coronary angiographic images
NCT Number: NCT06039748
Coronary angiography-derived FFR assessment (AngioQFA) is a novel technique for physiological lesion assessment based on 3-dimensional (3D) quantitative coronary angiography (QCA) and virtual hyperemic flow derived from contrast frame count without drug-induced hyperemia. The goal of this prospective, multicenter trial is to compare the diagnostic performance of AngioQFA with invasive FFR as the reference standard. The secondary purpose is to compare the diagnostic accuracies of the computational fluid dynamics (CFD)-based index of microcirculatory resistance (IMR) using wire-based IMR as the reference standard.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Jieyang People's Hospital, Jieyang, Guangdong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients meeting any of the following criteria will be excluded:
FFR measured by pressure wire, AngioQFA computed by coronary angiographic images
Time frame: 1 hour
Positive FFR is defined as FFR≤0.80. Positive AngioQFA is defined as AngioQFA≤0.80.
Time frame: 1 hour
Positive IMR is defined as IMR≥25. Positive AngioIMR is defined as AngioIMR≥25.
Time frame: 1 hour
Negative FFR is defined as FFR>0.80. Negative AngioQFA is defined as AngioQFA>0.80.
Time frame: 1 hour
Negative IMR is defined as IMR<25. Negative AngioIMR is defined as AngioIMR<25.
Time frame: 1 hour
Diagnostic accuracy, positive predictive value and negative predictive value of AngioQFA versus wire-based FFR for demonstration of coronary ischemia on a per-patient basis.
Time frame: 1 hour
Diagnostic performance includes sensitivity, specificity, accuracy, positive predictive value and negative predictive value.
Time frame: 1 hour
AUC and ROC of AngioQFA Versus wire-based FFR for demonstration of ischemia on a per-vessel basis and a per-patient basis.
Time frame: 1 hour
The consistency of AngioQFA Versus wire-based FFR for demonstration of ischemia on a per-vessel basis and a per-patient basis.
Time frame: 1 hour
Diagnostic accuracy, positive predictive value and negative predictive value of AngioIMR versus wire-based IMR for demonstration of coronary microvascular dysfunction on a per-patient basis.
Time frame: 1 hour
Diagnostic performance includes sensitivity, specificity, accuracy, positive predictive value and negative predictive value.
Time frame: 1 hour
AUC and ROC of AngioIMR Versus wire-based IMR for demonstration of coronary microvascular dysfunction on a per-vessel basis and a per-patient basis.
Time frame: 1 hour
The consistency of AngioIMR Versus wire-based IMR for demonstration of coronary microvascular dysfunction on a per-vessel basis and a per-patient basis.
Time frame: 1 hour
FFR≤0.80 is defined as "positive", FFR>0.80 is defined as "negative"; DS%≥50% is defined as "positive", DS%<50% is defined as "negative".
Time frame: 1 hour
Postoperative FFR≤0.89 was defined as "positive", FFR>0.89 is defined as "negative".
Time frame: 1 hour
The Pearson correlation coefficient and consistency of AngioQFA Versus wire-based FFR for demonstration of ischemia on a per-vessel basis after PCI.
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
Industry
Diagnostic Performance of Angiography-Derived Quantitative Functional Assessment Compared to Pressure-Derived Fractional Flow Reserve and Index of Microcirculatory Resistance: The FAIR Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01583608
Arterial Occlusive Diseases, Arteriosclerosis
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial DetailsNCT04624854
Acute Coronary Syndrome, Arterial Occlusive Diseases
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT03405506
Arterial Occlusive Diseases, Arteriosclerosis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04343209
Arterial Occlusive Diseases, Arteriosclerosis
Miami, Florida, United States
View Trial Details